LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

PNPLA domain-containing protein

Quick info Localization Phosphorylation Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
PNPLA domain-containing protein
Gene product:
Patatin-like phospholipase - putative
Species:
Leishmania infantum
UniProt:
A4IA67_LEIIN
TriTrypDb:
LINF_340035800
Length:
432

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 12
NetGPI no yes: 0, no: 12
Cellular components
Term Name Level Count
GO:0005737 cytoplasm 2 1
GO:0005811 lipid droplet 5 1
GO:0016020 membrane 2 9
GO:0043226 organelle 2 1
GO:0043228 non-membrane-bounded organelle 3 1
GO:0043229 intracellular organelle 3 1
GO:0043232 intracellular non-membrane-bounded organelle 4 1
GO:0110165 cellular anatomical entity 1 9

Phosphorylation

Promastigote: 419

Expansion

Sequence features

A4IA67
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A4IA67

Function

Biological processes
Term Name Level Count
GO:0006629 lipid metabolic process 3 13
GO:0008152 metabolic process 1 13
GO:0009056 catabolic process 2 13
GO:0016042 lipid catabolic process 4 13
GO:0044238 primary metabolic process 2 13
GO:0071704 organic substance metabolic process 2 13
GO:1901575 organic substance catabolic process 3 13
GO:0006638 neutral lipid metabolic process 4 1
GO:0006639 acylglycerol metabolic process 5 1
GO:0006641 triglyceride metabolic process 6 1
GO:0009987 cellular process 1 1
GO:0019433 triglyceride catabolic process 7 1
GO:0042592 homeostatic process 3 1
GO:0044237 cellular metabolic process 2 1
GO:0044242 cellular lipid catabolic process 4 1
GO:0044248 cellular catabolic process 3 1
GO:0044255 cellular lipid metabolic process 3 1
GO:0046461 neutral lipid catabolic process 5 1
GO:0046464 acylglycerol catabolic process 6 1
GO:0046486 glycerolipid metabolic process 4 1
GO:0046503 glycerolipid catabolic process 5 1
GO:0048878 chemical homeostasis 4 1
GO:0055088 lipid homeostasis 5 1
GO:0065007 biological regulation 1 1
GO:0065008 regulation of biological quality 2 1
Molecular functions
Term Name Level Count
GO:0003824 catalytic activity 1 13
GO:0016787 hydrolase activity 2 13
GO:0004806 triglyceride lipase activity 5 1
GO:0016298 lipase activity 4 1
GO:0016788 hydrolase activity, acting on ester bonds 3 1
GO:0052689 carboxylic ester hydrolase activity 4 1

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 277 281 PF00656 0.399
CLV_NRD_NRD_1 400 402 PF00675 0.503
CLV_NRD_NRD_1 423 425 PF00675 0.444
CLV_PCSK_KEX2_1 423 425 PF00082 0.460
CLV_PCSK_KEX2_1 73 75 PF00082 0.523
CLV_PCSK_PC1ET2_1 73 75 PF00082 0.528
CLV_PCSK_SKI1_1 123 127 PF00082 0.576
CLV_PCSK_SKI1_1 146 150 PF00082 0.614
CLV_PCSK_SKI1_1 283 287 PF00082 0.625
CLV_PCSK_SKI1_1 336 340 PF00082 0.358
CLV_PCSK_SKI1_1 364 368 PF00082 0.354
DOC_CDC14_PxL_1 412 420 PF14671 0.674
DOC_MAPK_gen_1 283 291 PF00069 0.459
DOC_MAPK_gen_1 383 393 PF00069 0.576
DOC_MAPK_MEF2A_6 315 324 PF00069 0.375
DOC_MAPK_MEF2A_6 35 42 PF00069 0.388
DOC_PP1_RVXF_1 362 368 PF00149 0.584
DOC_PP1_RVXF_1 71 78 PF00149 0.315
DOC_PP2B_LxvP_1 247 250 PF13499 0.308
DOC_USP7_MATH_1 8 12 PF00917 0.541
DOC_USP7_UBL2_3 398 402 PF12436 0.699
DOC_WW_Pin1_4 211 216 PF00397 0.349
DOC_WW_Pin1_4 3 8 PF00397 0.496
DOC_WW_Pin1_4 416 421 PF00397 0.629
LIG_14-3-3_CanoR_1 112 116 PF00244 0.344
LIG_14-3-3_CanoR_1 167 173 PF00244 0.354
LIG_14-3-3_CanoR_1 354 360 PF00244 0.586
LIG_Actin_WH2_2 122 139 PF00022 0.396
LIG_APCC_ABBA_1 320 325 PF00400 0.368
LIG_BIR_II_1 1 5 PF00653 0.547
LIG_BRCT_BRCA1_1 112 116 PF00533 0.407
LIG_BRCT_BRCA1_1 381 385 PF00533 0.595
LIG_deltaCOP1_diTrp_1 31 42 PF00928 0.446
LIG_EH1_1 303 311 PF00400 0.438
LIG_FHA_1 124 130 PF00498 0.325
LIG_FHA_1 212 218 PF00498 0.361
LIG_FHA_1 220 226 PF00498 0.288
LIG_FHA_1 354 360 PF00498 0.645
LIG_FHA_2 15 21 PF00498 0.548
LIG_IRF3_LxIS_1 322 329 PF10401 0.472
LIG_LIR_Gen_1 113 124 PF02991 0.339
LIG_LIR_Gen_1 173 183 PF02991 0.327
LIG_LIR_Gen_1 295 305 PF02991 0.414
LIG_LIR_Gen_1 92 103 PF02991 0.368
LIG_LIR_Nem_3 113 119 PF02991 0.359
LIG_LIR_Nem_3 170 175 PF02991 0.322
LIG_LIR_Nem_3 243 247 PF02991 0.353
LIG_LIR_Nem_3 295 300 PF02991 0.431
LIG_LIR_Nem_3 303 308 PF02991 0.358
LIG_LIR_Nem_3 345 349 PF02991 0.595
LIG_LIR_Nem_3 382 388 PF02991 0.544
LIG_LIR_Nem_3 92 98 PF02991 0.351
LIG_MYND_1 416 420 PF01753 0.617
LIG_PCNA_yPIPBox_3 377 388 PF02747 0.642
LIG_Pex14_1 47 51 PF04695 0.281
LIG_Pex14_2 240 244 PF04695 0.314
LIG_Pex14_2 48 52 PF04695 0.343
LIG_SH2_CRK 175 179 PF00017 0.406
LIG_SH2_CRK 255 259 PF00017 0.380
LIG_SH2_CRK 95 99 PF00017 0.401
LIG_SH2_NCK_1 57 61 PF00017 0.396
LIG_SH2_PTP2 313 316 PF00017 0.410
LIG_SH2_PTP2 323 326 PF00017 0.369
LIG_SH2_SRC 297 300 PF00017 0.442
LIG_SH2_STAT3 24 27 PF00017 0.419
LIG_SH2_STAT5 124 127 PF00017 0.306
LIG_SH2_STAT5 229 232 PF00017 0.356
LIG_SH2_STAT5 269 272 PF00017 0.321
LIG_SH2_STAT5 297 300 PF00017 0.439
LIG_SH2_STAT5 313 316 PF00017 0.302
LIG_SH2_STAT5 323 326 PF00017 0.347
LIG_SH2_STAT5 51 54 PF00017 0.366
LIG_SH2_STAT5 69 72 PF00017 0.425
LIG_SH3_3 189 195 PF00018 0.330
LIG_SH3_3 236 242 PF00018 0.387
LIG_SH3_3 384 390 PF00018 0.587
LIG_SUMO_SIM_par_1 218 226 PF11976 0.327
LIG_SUMO_SIM_par_1 355 361 PF11976 0.585
LIG_TRAF2_1 373 376 PF00917 0.640
LIG_WRC_WIRS_1 169 174 PF05994 0.401
MOD_CDK_SPK_2 211 216 PF00069 0.375
MOD_CDK_SPxxK_3 416 423 PF00069 0.638
MOD_CK1_1 11 17 PF00069 0.503
MOD_CK1_1 170 176 PF00069 0.403
MOD_CK1_1 211 217 PF00069 0.397
MOD_CK1_1 3 9 PF00069 0.544
MOD_CK1_1 358 364 PF00069 0.563
MOD_CK1_1 369 375 PF00069 0.603
MOD_CK1_1 379 385 PF00069 0.611
MOD_CK1_1 396 402 PF00069 0.630
MOD_CK2_1 197 203 PF00069 0.420
MOD_CK2_1 293 299 PF00069 0.438
MOD_CK2_1 369 375 PF00069 0.661
MOD_Cter_Amidation 399 402 PF01082 0.480
MOD_Cter_Amidation 71 74 PF01082 0.549
MOD_GlcNHglycan 104 107 PF01048 0.511
MOD_GlcNHglycan 150 153 PF01048 0.612
MOD_GlcNHglycan 225 228 PF01048 0.532
MOD_GlcNHglycan 407 410 PF01048 0.490
MOD_GlcNHglycan 61 64 PF01048 0.543
MOD_GlcNHglycan 80 83 PF01048 0.390
MOD_GlcNHglycan 91 94 PF01048 0.496
MOD_GSK3_1 10 17 PF00069 0.514
MOD_GSK3_1 163 170 PF00069 0.357
MOD_GSK3_1 178 185 PF00069 0.272
MOD_GSK3_1 219 226 PF00069 0.317
MOD_GSK3_1 36 43 PF00069 0.327
MOD_GSK3_1 366 373 PF00069 0.646
MOD_GSK3_1 85 92 PF00069 0.327
MOD_N-GLC_1 211 216 PF02516 0.617
MOD_NEK2_1 168 173 PF00069 0.381
MOD_NEK2_1 182 187 PF00069 0.219
MOD_NEK2_1 326 331 PF00069 0.413
MOD_NEK2_1 353 358 PF00069 0.597
MOD_NEK2_1 393 398 PF00069 0.653
MOD_NEK2_1 59 64 PF00069 0.342
MOD_NEK2_1 85 90 PF00069 0.330
MOD_NEK2_2 111 116 PF00069 0.423
MOD_PKA_2 111 117 PF00069 0.327
MOD_PKA_2 178 184 PF00069 0.389
MOD_PKA_2 353 359 PF00069 0.631
MOD_PKA_2 376 382 PF00069 0.575
MOD_PKA_2 75 81 PF00069 0.361
MOD_Plk_1 219 225 PF00069 0.386
MOD_Plk_1 231 237 PF00069 0.367
MOD_Plk_1 36 42 PF00069 0.299
MOD_Plk_4 111 117 PF00069 0.336
MOD_Plk_4 156 162 PF00069 0.393
MOD_Plk_4 178 184 PF00069 0.355
MOD_Plk_4 240 246 PF00069 0.325
MOD_Plk_4 293 299 PF00069 0.432
MOD_ProDKin_1 211 217 PF00069 0.352
MOD_ProDKin_1 3 9 PF00069 0.497
MOD_ProDKin_1 416 422 PF00069 0.626
MOD_SUMO_for_1 196 199 PF00179 0.415
MOD_SUMO_for_1 285 288 PF00179 0.383
TRG_DiLeu_BaEn_1 307 312 PF01217 0.362
TRG_DiLeu_BaLyEn_6 164 169 PF01217 0.403
TRG_DiLeu_BaLyEn_6 280 285 PF01217 0.396
TRG_DiLeu_BaLyEn_6 361 366 PF01217 0.551
TRG_ENDOCYTIC_2 175 178 PF00928 0.331
TRG_ENDOCYTIC_2 255 258 PF00928 0.319
TRG_ENDOCYTIC_2 263 266 PF00928 0.265
TRG_ENDOCYTIC_2 297 300 PF00928 0.464
TRG_ENDOCYTIC_2 323 326 PF00928 0.331
TRG_ENDOCYTIC_2 350 353 PF00928 0.560
TRG_ENDOCYTIC_2 57 60 PF00928 0.391
TRG_ENDOCYTIC_2 95 98 PF00928 0.399
TRG_ER_diArg_1 143 146 PF00400 0.425
TRG_ER_diArg_1 235 238 PF00400 0.386
TRG_ER_diArg_1 74 77 PF00400 0.307
TRG_NES_CRM1_1 268 280 PF08389 0.256
TRG_Pf-PMV_PEXEL_1 283 287 PF00026 0.578
TRG_Pf-PMV_PEXEL_1 347 351 PF00026 0.452

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N0P509 Leptomonas seymouri 75% 100%
A0A0S4IY58 Bodo saltans 34% 100%
A0A0S4J309 Bodo saltans 37% 92%
A0A1X0P9X6 Trypanosomatidae 45% 100%
A0A3S5H7X3 Leishmania donovani 100% 100%
A0A422N4J2 Trypanosoma rangeli 42% 100%
A4HB10 Leishmania braziliensis 81% 100%
C9ZM39 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 42% 100%
E9B580 Leishmania mexicana (strain MHOM/GT/2001/U1103) 91% 100%
Q4Q2Q3 Leishmania major 93% 100%
V5DLV7 Trypanosoma cruzi 42% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS